Ferric carboxymaltose in patients with pulmonary arterial hypertension and iron deficiency: a long‐term study

Ferric carboxymaltose in patients with pulmonary arterial hypertension and iron deficiency: a long‐term study

Abstract Background Pulmonary arterial hypertension (PAH) is a progressive disease with limited survival. Iron deficiency (ID) correlates with disease severity and mortality. While oral iron supplementation was shown to be insufficient in such patients, the potential impact of parenteral iron on cli...

Full description

Bibliographic Details
Main Authors: Tilmann Kramer, Max Wissmüller, Kristiana Natsina, Felix Gerhardt, Henrik tenFreyhaus, Daniel Dumitrescu, Thomas Viethen, Martin Hellmich, Stephan Baldus, Stephan Rosenkranz
Format: Article
Language:English
Published: Wiley 2021-12-01
Series:Journal of Cachexia, Sarcopenia and Muscle
Subjects:
Pulmonary arterial hypertension (PAH)
Iron deficiency
Iron
Ferric carboxymaltose
Online Access:https://doi.org/10.1002/jcsm.12764

Internet

https://doi.org/10.1002/jcsm.12764

Similar Items